IL-33 contributes to sepsis-induced long-Term immunosuppression by expanding the regulatory T cell population

Nature Communications

Volumn 8, Issue , 2017, Pages

  Nascimento, Daniele C ^a   Melo, Paulo H ^a   Piñeros, Annie R ^a   Ferreira, Raphael G ^a   Colón, David F ^a   Donate, Paula B ^a   Castanheira, Fernanda V ^a   Gozzi, Aline ^a   Czaikoski, Paula G ^a   Niedbala, Wanda ^b   Borges, Marcos C ^a   Zamboni, Dario S ^a   Liew, Foo Y ^b,c   Cunha, Fernando Q ^a   Alves Filho, Jose C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 33; RECOMBINANT CYTOKINE;

BLOOD; CELLS AND CELL COMPONENTS; IMMUNE SYSTEM; INJURY; POLARIZATION; PROTEIN; RODENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLARIZATION; REGULATORY T LYMPHOCYTE; SEPSIS; SEPTIC SHOCK; TISSUE INJURY; AGED; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DEFICIENCY; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED;

MUS;

AGED; ANIMALS; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-10; INTERLEUKIN-33; MACROPHAGES; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; SEPSIS; T-LYMPHOCYTES, REGULATORY;

EID: 85017030505     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14919     Document Type: Article

References (57)

1. Vincent, J. L., Opal, S. M., Marshall, J. C. & Tracey, K. J. Sepsis definitions: Time for change. Lancet 381, 774-775 (2013).
2. Martin, G. S., Mannino, D. M., Eaton, S. & Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554 (2003).
3. Quartin, A. A., Schein, R. M., Kett, D. H. & Peduzzi, P. N. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. J. Am. Med. Assoc. 277, 1058-1063 (1997).
4. Angus, D. C. The lingering consequences of sepsis: A hidden public health disaster? J. Am. Med. Assoc. 304, 1833-1834 (2010).
5. Wang, T. et al. Subsequent infections in survivors of sepsis: epidemiology and outcomes. J. Intensive Care Med. 29, 87-95 (2014).
6. Benjamim, C. F., Hogaboam, C. M., Lukacs, N. W. & Kunkel, S. L. Septic mice are susceptible to pulmonary aspergillosis. Am. J. Pathol. 163, 2605-2617 (2003).
7. Boomer, J. S. et al. Immunosuppression in patients who die of sepsis and multiple organ failure. J. Am. Med. Assoc. 306, 2594-2605 (2011).
8. Otto, G. P. et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183 (2011).
9. Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862-874 (2013).
10. Venet, F. et al. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (+)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35, 678-686 (2009).
11. Hiraki, S. et al. Neutralization of interleukin-10 or transforming growth factorb decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival. Surgery 151, 313-322 (2012).
12. Nascimento, D. C. et al. Role of regulatory T cells in long-Term immune dysfunction associated with severe sepsis. Crit Care Med. 38, 1718-1725 (2010).
13. Cavassani, K. A. et al. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood 115, 4403-4411 (2010).
14. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 23, 479-490 (2005).
15. Liew, F. Y., Pitman, N. I. & McInnes, I. B. Disease-Associated functions of IL-33: The new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103-110 (2010).
16. Mirchandani, A. S., Salmond, R. J. & Liew, F. Y. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol. 33, 389-396 (2012).
17. Kurowska-Stolarska, M. et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183, 6469-6477 (2009).
18. Turnquist, H. R. et al. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 187, 4598-4610 (2011).
19. Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568 (2014).
20. Morita, H. et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity 43, 175-186 (2015).
21. Vasanthakumar, A. et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16, 276-285 (2015).
22. Arpaia, N. et al. A distinct function of regulatory T cells in tissue protection. Cell 162, 1078-1089 (2015).
23. Benjamim, C. F., Lundy, S. K., Lukacs, N. W., Hogaboam, C. M. & Kunkel, S. L. Reversal of long-Term sepsis-induced immunosuppression by dendritic cells. Blood 105, 3588-3595 (2005).
24. Kaynar, A. M. et al. Effects of intra-Abdominal sepsis on atherosclerosis in mice. Crit. Care 18, 469 (2014).
25. Rocheteau, P. et al. Sepsis induces long-Term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat. Commun. 6, 10145 (2015).
26. Portella, V. G. et al. Sepsis-surviving mice are more susceptible to a secondary kidney insult. Crit. Care Med. 41, 1056-1068 (2013).
27. Drechsler, S. et al. Why do they die? Comparison of selected aspects of organ injury and dysfunction in mice surviving and dying in acute abdominal sepsis. Intensive Care Med. Exp. 3, 48 (2015).
28. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
29. Chang, Y. J. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631-638 (2011).
30. Monticelli, L. A. et al. Innate lymphoid cells promote lung-Tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045-1054 (2011).
31. Salmond, R. J. et al. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J. Allergy Clin. Immunol. 130, 1159-1166.e1156 (2012).
32. Yasuda, K. et al. Contribution of IL-33-Activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl Acad. Sci. USA 109, 3451-3456 (2012).
33. Kaplan, M. H., Schindler, U., Smiley, S. T. & Grusby, M. J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319 (1996).
34. Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896 (2010).
35. Ruffell, D. et al. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl Acad. Sci. USA 106, 17475-17480 (2009).
36. Ghosn, E. E. et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc. Natl Acad. Sci. USA 107, 2568-2573 (2010).
37. Jenkins, S. J. et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284-1288 (2011).
38. Benoit, M., Desnues, B. & Mege, J. L. Macrophage polarization in bacterial infections. J. Immunol. 181, 3733-3739 (2008).
39. Pichery, M. et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 188, 3488-3495 (2012).
40. Cayrol, C. & Girard, J. P. IL-33: An alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 31, 31-37 (2014).
41. Polumuri, S. K. et al. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 189, 50-60 (2012).
42. Su, Z. et al. Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation. Mucos. Immunol. 6, 921-930 (2013).
43. Brunialti, M. K. et al. Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis. PLoS ONE 7, e37393 (2012).
44. Matsukawa, A. et al. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164, 2738-2744 (2000).
45. Chen, F. et al. An essential role for TH2-Type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 18, 260-266 (2012).
46. Alves-Filho, J. C. et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 16, 708-712 (2010).
47. Savage, N. D. et al. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J. Immunol. 181, 2220-2226 (2008).
48. Traeger, T. et al. Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis. Infect. Immun. 76, 5285-5293 (2008).
49. Molinaro, R. et al. CCR4 controls the suppressive effects of regulatory T cells on early and late events during severe sepsis. PLoS ONE 10, e0133227 (2015).
50. Hsu, P. et al. IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1. J. Immunol. 195, 3665-3674 (2015).
51. Song, G. Y., Chung, C. S., Chaudry, I. H. & Ayala, A. IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. Surgery 128, 133-138 (2000).
52. Gajardo, T., Morales, R. A., Campos-Mora, M., Campos-Acuña, J. & Pino-Lagos, K. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3(+) regulatory T cells in skin-Transplanted mice. Immunology 146, 81-88 (2015).
53. Delano, M. J. et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474 (2007).
54. Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E. & McKenzie, A. N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191, 1069-1076 (2000).
55. Brint, E. K. et al. ST2 is an inhibitor of interleukin 1 receptor and Tolllike receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5, 373-379 (2004).
56. Levy, M. M. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250-1256 (2003).
57. Zamboni, D. S. et al. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7, 318-325 (2006).